Acute Kidney Injury, Renal Replacement Therapy, and Medication Dosing in Renal Dysfunction

This module is part of the Advanced Critical Care Therapeutics Series.

Access in-depth instruction concerning the pharmacotherapeutic management of acute kidney injury, principles of renal replacement therapy and concepts of medication dosing in renal dysfunction. Didactic knowledge of the etiology, pathophysiology and drug therapy management of acute kidney injury will be provided. We’ll also discuss principles of renal replacement therapy and their effect on medication dosing, and you’ll learn about general concepts regarding dosing medications in patients with both acute and chronic renal function. Following completion of this CE topic, participants will have the most up-to-date information concerning acute kidney injury, renal replacement therapy, and medication dosing in renal dysfunction.

Presented By: Stacey K. Dull, Pharm.D., BCPS

Objectives 

• Define acute kidney injury (AKI)
• Recognize risk factors for the development of AKI
• Discuss strategies to prevent and treat AKI
• Identify renal replacement therapies (RRT)
• Recognize and use equations to estimate renal function
• List commonly used ICU medications that require dose adjustments with decreased renal function
• Adjust medication doses and frequencies in the setting of changing renal function

Education Credit

Category 1
Creighton University Health Sciences Continuing Education designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA accepts AMA category 1 credit for the PRA from organizations accredited by ACCME.

Nurse CE
Creighton University Health Sciences Continuing Education designates this activity for 2.0 contact hours for nurses. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacy
Creighton University Health Sciences Continuing Education (HSCE) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE). This enduring material, Acute Kidney Injury and Medication Dosing in Renal Dysfunction, is accredited for 2.0 hour(s) for completion of all CE sessions.  Term of approval is from this date on August 22, 2020 until August 21, 2023.  The Advanced Critical Care Therapeutics is a knowledge-based CE activity.

Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Creighton University Health Sciences Continuing Education. Creighton University Health Sciences Continuing Education (HSCE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.